| 注册
首页|期刊导航|中国药业|抗溃疡药物雷贝拉唑的现代研究进展

抗溃疡药物雷贝拉唑的现代研究进展

李祎 王善春

中国药业2016,Vol.25Issue(13):1-4,4.
中国药业2016,Vol.25Issue(13):1-4,4.

抗溃疡药物雷贝拉唑的现代研究进展

Advances in Modern Research of Anti-Ulcer Drug Rabeprazole

李祎 1王善春2

作者信息

  • 1. 江苏省连云港市第一人民医院,江苏连云港222002
  • 2. 正大天晴药业集团股份有限公司,江苏南京210000
  • 折叠

摘要

Abstract

Objective To introduce the synthesis pathways and clinical applications of a novel antiulcer proton pump inhibitors-rabeprazole. Methods International and domestic researches published since 2000 on rabeprazole were retrieved. Results and Conclusion Rabeprazole as a new generation of proton pump inhibitors can quickly inhibit the gastric acid secretion and is suitable for gastric ulcer, duodenal ulcer, erosive stomach-esophageal reflux disease, and helicobacter pylori infection. Rabeprazole has a broad application prospect on clinic because of its good clinical efficacy and little side effect.

关键词

雷贝拉唑/抗溃疡/质子泵抑制剂/进展

Key words

rabeprazole/anti-ulcerative/proton pump inhibitor/advarces

分类

医药卫生

引用本文复制引用

李祎,王善春..抗溃疡药物雷贝拉唑的现代研究进展[J].中国药业,2016,25(13):1-4,4.

基金项目

国家科技重大专项子任务,项目编号2014ZX09201001006003,2013ZX09201006。 ()

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文